希腊经皮冠状动脉介入治疗注册研究中心的组织、结构和数据：通向结果研究的一步。

Organization, structure and data of the Hellenic Heart Registry on Percutaneous Coronary Interventions: a step forward towards outcomes research.

机构信息

Athens Medical Center, Cardiac Catheterization Laboratory, Athens, Greece.

出版信息

Hellenic J Cardiol. 2014 May-Jun;55(3):227-34.

Abstract

INTRODUCTION

The Hellenic Heart Registry on Percutaneous Coronary Interventions (HHR-PCI) was a prospective, observational registry of patients with stable angina or acute coronary syndromes who underwent percutaneous coronary intervention (PCI) between January 2008 and October 2010.

METHODS

HHR-PCI was a database that used a secure web-based interface for data entry by individual users. All PCI centers and operators were invited to participate. The participating PCI centers were geographically divided into three main regions: Athens Metro Area, Thessaloniki Metro Area, and Rest of Greece. Indications, demographics, procedural characteristics, and in-hospital outcomes (death, myocardial infarction, cerebrovascular accidents) were recorded.

RESULTS

Eighteen (18) centers participated in the registry (2008-2010) in a systematic fashion, entering complete data for 3441 patients (males 83.1%, mean age 64.1 years, 5521 lesions). PCI was elective in 47.1% of patients and was used to treat an acute coronary syndrome in 52.5%. There were 742 (21.6%) patients treated for ST-segment elevation myocardial infarction, with 225 (30.3%) receiving primary PCI (mean door-to-balloon time 140 minutes). The mean numbers of stents per lesion and per patient were 1.14 and 1.74, respectively, with drug eluting stents being used in 74.2% of coronary lesions. Periprocedural complications were observed in 105 patients (3.1%), while the incidence of in-hospital death, myocardial infarction, and cerebrovascular event were 0.5%, 1%, and 0.6%, respectively.

CONCLUSIONS

HHR-PCI was the first web-based national PCI registry in Greece and has provided useful insights regarding the practice of interventional cardiology in this country. Efforts should be made to maintain and extend this type of PCI registry, with a view to improving quality and outcomes research in the field of interventional cardiology.

摘要

简介

希腊经皮冠状动脉介入治疗注册研究（HHR-PCI）是一项前瞻性、观察性注册研究，纳入了 2008 年 1 月至 2010 年 10 月期间接受经皮冠状动脉介入治疗（PCI）的稳定性心绞痛或急性冠状动脉综合征患者。

方法

HHR-PCI 是一个数据库，使用安全的基于网络的界面供个人用户输入数据。所有 PCI 中心和操作人员均被邀请参与。参与的 PCI 中心按地理位置分为三个主要区域：雅典都会区、塞萨洛尼基都会区和希腊其他地区。记录了适应证、人口统计学特征、手术特征以及院内结局（死亡、心肌梗死、脑血管意外）。

结果

18 个中心（2008-2010 年）系统地参与了该注册研究，共纳入 3441 例患者（男性 83.1%，平均年龄 64.1 岁，5521 处病变）的完整数据。47.1%的患者行 PCI 治疗为择期，52.5%的患者行 PCI 治疗为急性冠状动脉综合征。有 742 例（21.6%）患者因 ST 段抬高型心肌梗死接受治疗，其中 225 例（30.3%）接受直接 PCI（平均门球时间 140 分钟）。每处病变和每位患者的平均支架数分别为 1.14 和 1.74，其中 74.2%的冠状动脉病变使用了药物洗脱支架。105 例（3.1%）患者发生围手术期并发症，院内死亡率、心肌梗死率和脑血管事件发生率分别为 0.5%、1%和 0.6%。